Financial statements Hemolens Diagnostics
Cash inflows of HEMOLENS DIAGNOSTICS
|
Year
|
2018
|
2019
|
2020
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | - | 2 829 457,61 | - | - | -29 156 795,19 |
| Net cash flow from investing activities | - | -82 616,86 | - | - | -568 853,77 |
| Net cash flow from financial activities | - | 0,00 | - | - | 34 288 538,36 |
| Total net cash flow | - | 2 746 840,75 | - | - | 4 562 889,40 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.